UNSPSC 51172404: Alginic acid/aluminum hydroxide/magnesium trisilicate/sodium bicarbonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA199. This VA Drug Class (GA199) classifies this compound as belonging to the group ANTACIDS, OTHER.

UNSPSC 51172404 Alginic acid/aluminum hydroxide/magnesium trisilicate/sodium bicarbonate is a Commodity code that, based on recent state and local opportunities, does not align with actual procurement activity under this designation. The three most recent opportunities posted under or near this code involve offender drug testing services, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceutical distribution — none of which are antacid formulations or the specific chemical compounds the code nominally describes. The mismatch suggests either a data-entry error in how opportunities are tagged to this code or a divergence between the code's nominal scope and what state and local buyers are actually sourcing through it.

The recent opportunities span Texas and Minnesota, reflecting different procurement needs within the pharmaceutical and testing services ecosystem. Collin County Community Supervision and Corrections Department posted an RFP (2026-327, due July 23, 2026) for offender specimen collection and drug testing services valued at approximately $600,000 over two years with optional renewals. The Texas Health and Human Services Commission issued an exploratory RFI (HHS0017013, April 3, 2026) to gather vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed through authorized wholesalers, effective July 1, 2026. The code shows little relevant recent activity for the antacid compound it nominally describes.